Pregnancy

If treatment for obsessive-compulsive disorder or major depressive disorder is initiated for the first time during pregnancy, fluvoxamine is not one of the preferred SSRIs. Therapy with antidepressants during pregnancy should be individualized; treatment with antidepressant medication is recommended for pregnant patients with severe major depressive disorder

Lactation

The decision to breastfeed during fluvoxamine therapy should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and the benefits of treatment to the mother.

Warnings

Black Box Warning: Increased suicidal risk in pediatrics and young adults with other MDD and other psychiatric disorders , Contraindicated: MAO inhibitors , Warnings: CNS depression, seizure disorder, liver impairment